Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2002 1
2003 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity.
Laureti S, Candeloro P, Aglietti MC, Giordano R, Arvat E, Ghigo E, Santeusanio F, Falorni A. Laureti S, et al. Among authors: santeusanio f. Clin Endocrinol (Oxf). 2002 Nov;57(5):677-83. doi: 10.1046/j.1365-2265.2002.01651.x. Clin Endocrinol (Oxf). 2002. PMID: 12390344
In 21OHAb-positive subjects, the adrenocortical function is best evaluated by peak cortisol (F) levels after the low-dose (1 micro g) ACTH stimulation test (LDT). ...DESIGN AND PATIENTS: We studied 12 subjects positive for 21OHAb, in the absence of clinical signs of adrena …
In 21OHAb-positive subjects, the adrenocortical function is best evaluated by peak cortisol (F) levels after the low-dose (1 micro g) …
Pharmacokinetic profile and endocrine effects of posatirelin treatment in healthy elderly subjects.
Reboldi G, Parnetti L, Santeusanio F, Ambrosoli L, Palumbo B, Cherubini A, Girardello R, Poli A, Lowenthal DT, Senin U. Reboldi G, et al. Among authors: santeusanio f. J Clin Pharmacol. 1996 Sep;36(9):823-31. doi: 10.1002/j.1552-4604.1996.tb04256.x. J Clin Pharmacol. 1996. PMID: 8889903
Peak plasma concentration (Cmax), time of peak plasma concentration (tmax), area under the plasma concentration-time curve from time zero to infinity (AUC0-infinity), elimination half-life (t1/2), and total clearance (CI/F) were measured after single-dose intramuscular inj …
Peak plasma concentration (Cmax), time of peak plasma concentration (tmax), area under the plasma concentration-time curve from time zero to …
Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study.
Riccardi G, Giacco R, Parillo M, Turco S, Rivellese AA, Ventura MR, Contadini S, Marra G, Monteduro M, Santeusanio F, Brunetti P, Librenti MC, Pontiroli AE, Vedani P, Pozza G, Bergamini L, Bianchi C. Riccardi G, et al. Among authors: santeusanio f. Diabet Med. 1999 Mar;16(3):228-32. doi: 10.1046/j.1464-5491.1999.00047.x. Diabet Med. 1999. PMID: 10227568 Clinical Trial.

RESULTS: At the end of 24 weeks of treatment the intention to treat analysis showed that acarbose compared with placebo decreased 2 h postprandial plasma glucose levels (12.23 +/- 0.83 vs. 14.93 +/- 0.87 mmol/l; F = 6.1, P < 0.02) (least square means +/- SEM). No signif

…
RESULTS: At the end of 24 weeks of treatment the intention to treat analysis showed that acarbose compared with placebo decreased 2 h postpr …
-to: Nicoletti F, Conget L, Di Mauro M et al. (2002) Serum concentrations of the interferon-alpha-inducible chemokine IP-10/CXCL10 are augmented in both newly-diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45:1107-1110.
Rotondi M, Romagnani P, Brozzetti A, Santeusanio F, Serio M, Falorni A. Rotondi M, et al. Among authors: santeusanio f. Diabetologia. 2003 Jul;46(7):1020-1. doi: 10.1007/s00125-003-1134-4. Epub 2003 Jun 18. Diabetologia. 2003. PMID: 12819903 No abstract available.